Cisplatin Interactions
There are 435 drugs known to interact with cisplatin, along with 7 disease interactions. Of the total drug interactions, 90 are major, 326 are moderate, and 19 are minor.
- View all 435 medications that may interact with cisplatin
- View cisplatin disease interactions (7)
Most frequently checked interactions
View interaction reports for cisplatin and the medicines listed below.
- Adriamycin (doxorubicin)
- Adriamycin (doxorubicin)
- Aloxi (palonosetron)
- Aloxi (palonosetron)
- Ativan (lorazepam)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Avastin (bevacizumab)
- Compazine (prochlorperazine)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Decadron (dexamethasone)
- Gemzar (gemcitabine)
- Gemzar (gemcitabine)
- Herceptin (trastuzumab)
- Herceptin (trastuzumab)
- Neulasta (pegfilgrastim)
- Neulasta (pegfilgrastim)
- Taxol (paclitaxel)
- Taxol (paclitaxel)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
Cisplatin disease interactions
There are 7 disease interactions with cisplatin which include:
- infections
- hearing loss
- myelosuppression
- peripheral neuropathy
- renal dysfunction
- hemolytic anemia
- ocular toxicity
More about cisplatin
- cisplatin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.